[CYCC] YoY Quarter Result on 31-Dec-2011 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#Q4]
Profit Trend
QoQ- -6.18%
YoY- -15.32%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 247 299 5 175 138 187 251 -0.26%
PBT -5,907 -4,026 -5,067 -3,780 -3,323 -4,489 -8,181 -5.28%
Tax -1,108 -452 -637 -122 -151 -152 -238 29.20%
NP -4,799 -3,559 -4,764 -3,658 -3,172 -4,337 -7,943 -8.05%
Tax Rate - - - - - - - -
Total Cost 5,046 3,858 4,769 3,833 3,310 4,524 8,194 -7.75%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -1,942.91 -1,190.30 -95,280.00 -2,090.29 -2,298.55 -2,319.25 -3,164.54 -7.80%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -50.11 -44.87 -149.01 -113.25 -115.84 -229.70 -653.10 -34.80%
EPS Diluted -50.11 -44.87 -149.01 -112.22 -114.43 -229.70 -653.10 -34.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.